GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Savara Inc (STU:YB4P) » Definitions » General and Admin. Expense

Savara (STU:YB4P) General and Admin. Expense : €16.57 Mil (TTM As of Mar. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Savara General and Admin. Expense?

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. Savara's General and Admin. Expense for the three months ended in Mar. 2024 was €5.19 Mil. Its General and Admin. Expense for the trailing twelve months (TTM) ended in Mar. 2024 was €16.57 Mil.

Savara General and Admin. Expense Historical Data

The historical data trend for Savara's General and Admin. Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Savara General and Admin. Expense Chart

Savara Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
General and Admin. Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.77 11.73 10.93 10.32 14.37

Savara Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
General and Admin. Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.14 3.05 3.89 4.45 5.19

Savara General and Admin. Expense Calculation

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company.

General and Admin. Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €16.57 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Savara General and Admin. Expense Related Terms

Thank you for viewing the detailed overview of Savara's General and Admin. Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Savara (STU:YB4P) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Savara Inc (STU:YB4P) » Definitions » General and Admin. Expense
Comparable Companies
IGMS KYTX ENGN CDMO THRD ORIC EYPT LXRX YMAB MNMD OCSE:NOVO B VRTX REGN ASX:CSL MRNA XKRX:207940 XKRX:068270 XBRU:UCB BNTX XBRU:ARGX
Traded in Other Exchanges
SVRA:USA
Address
6836 Bee Cave Road, Building I, Suite 205, Austin, TX, USA, 78746
Website
https://www.savarapharma.com
Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's lead program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.

Savara (STU:YB4P) Headlines

No Headlines